A Phase 2, Placebo-Controlled Study of the Opioid Receptor Antagonist LY2196044 for the Treatment of Alcohol Dependence - Concepedia

Concepedia

Publication | Closed Access

A Phase 2, Placebo-Controlled Study of the Opioid Receptor Antagonist LY2196044 for the Treatment of Alcohol Dependence

13

Citations

26

References

2013

Year

Conrad J. Wong, Jennifer Witcher, Craig Mallinckrodt, Robert A. Dean, Raymond F. Anton, Yun-Fei Chen, Bonnie A. Fijal, Haojun Ouyang, Sweta Dharia, Scott S. Sundseth,

Alcoholism Clinical and Experimental Research

Abstract

The results from this proof-of-concept clinical trial warrant further evaluation of LY2196044 for the treatment of alcohol dependence.

References

	Year	Citations

Page 1